FDA Enhances Global Patient and Regulatory Collaborations in Oncology

In recognition of World Cancer Day 2024, the FDA and European Medicines Agency will collaborate to spotlight innovative cancer treatment advances for patients.

Medicine regulators should increase collaboration, says new report

FDA's Framework for Regulating Regenerative Medicine Will Improve Oversight

Project Community

Maria Golovina, MS MBA on LinkedIn: FDA Enhances Global Patient and Regulatory Collaborations in Oncology

Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Urge International Harmonization to Accelerate Cancer Drug Approvals at Annual Event

Kirsten Boyd Goldberg posted on LinkedIn

Kirsten Boyd Goldberg on LinkedIn: FDA issues final decision to withdraw approval of Pepaxto

Investigation of Elevated Lead Levels: Cinnamon Applesauce Pouches (November 2023) - US FDA

What Is FDA's Project Renewal? The Modernization Of Decades Old Oncology Drug Labels - MMS Holdings

FDA's CoGenT Global Revolutionizing Gene Therapy Regulations

Revision: FDA grants marketing authorization of the first two COVID-19 Serology Tests through De Novo Pathway - US FDA